Molbio Diagnostics Rs 940 Crore IPO From Aug 10
The Molbio Diagnostics public issue comprises a fresh issue of Rs 200 crore and an offer for sale of Rs 740 crore by existing shareholders.
Mumbai: Goa based Molbio Diagnostics, a molecular diagnostics company announced Rs 940 crore initial public offering in the price band of Rs768 to Rs 807 per equity share of Rs 1 face value each. The public issue opens of Aug.10 and close on August 12, 2026. The public issue comprises a fresh issue of Rs 200 crore and an offer for sale of Rs 740 crore by existing shareholders.
Molbio Diagnostics is engaged in the research, development, manufacturing, and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases. The net proceeds from the fresh issue will be used for funding capital expenditure towards the setting up of infrastructure for research and development facility, purchase of certain plant, machinery and other equipment for Goa and Visakhapatnam Units and for general corporate purposes.
